Related Experiment Video
Updated: Jun 18, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
Published on: May 12, 2023
Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated
Charles E Rupprecht1, Deborah Briggs, Catherine M Brown
1National Center for Zoonotic, Vector-Borne and Enteric Diseases, 1600 Clifton Road N.E., Atlanta, GA 30333, USA. cyr5@cdc.gov
Abstract:
After exposure, human rabies is preventable by prompt application of post-exposure prophylaxis. Historically, the total number of rabies vaccine doses administered during human prophylaxis has decreased, as modern biologics have improved and scientific knowledge has grown. A review of the literature on rabies virus pathogenesis, experimental animal studies, clinical trials, epidemiological surveillance, and economic analyses was conducted to determine the potential utility of reducing the current 5-dose intramuscular series of human rabies vaccine administered in the United States. Based upon the available evidence, a reduced schedule of cell-culture rabies vaccine, administered on days 0, 3, 7, and 14, given in conjunction with rabies immune globulin, was supported and recommended by the United States Advisory Committee on Immunization Practices.
Related Concept Videos
Rabies
Vaccinations
Smallpox
Cross-reactivity
Vaccines
Drug Accumulation During Multiple Dosing: Repetitive IV Injections

